Optimal Transferrin Saturation Levels for RLS and PLMs Management
For patients with end-stage renal disease (ESRD) and RLS, iron therapy should be initiated when transferrin saturation is below 20%; for general RLS populations, emerging evidence suggests targeting transferrin saturation ≤35% identifies patients most likely to benefit from iron supplementation.
Iron Parameter Thresholds by Population
ESRD Patients with RLS
The 2025 AASM guidelines provide the most specific threshold: IV iron sucrose is recommended when ferritin <200 ng/mL AND transferrin saturation <20% 1. This dual-parameter approach ensures appropriate patient selection in the dialysis population where iron metabolism is significantly altered.
General RLS Population
While the 2025 AASM guidelines reference "appropriate iron status" for general RLS patients receiving iron therapy 1, they defer to a "good practice statement for iron parameters" without specifying exact transferrin saturation cutoffs in the excerpts provided. However, recent research identifies transferrin saturation ≤35% as a more sensitive predictor of favorable treatment response than ferritin alone 2. This represents an important clinical refinement beyond traditional ferritin-only approaches.
Practical Algorithm for Iron Therapy Initiation
Step 1: Measure both ferritin and transferrin saturation
- Do not rely on ferritin alone
- TSAT provides critical information about functional iron availability
Step 2: Apply population-specific thresholds
For ESRD patients:
- Initiate IV iron when: Ferritin <200 ng/mL AND TSAT <20%
- Use IV iron sucrose as per guideline recommendation 1
For general RLS patients:
- Consider iron therapy when: TSAT ≤35% (even if ferritin appears adequate)
- Target ferritin >75-100 ng/mL as treatment goal 3
- IV ferric carboxymaltose (≥1000 mg total dose) is strongly recommended for moderate-to-severe RLS 1, 2
- Oral ferrous sulfate is appropriate for mild cases and children 1
Step 3: Monitor for response and safety
- Follow-up iron studies after treatment
- Risk of iron overload is low when TSAT remains <45% on consecutive visits 4
- Reassess if TSAT exceeds 45% on two consecutive measurements
Key Clinical Nuances
Why TSAT matters more than previously recognized: Transferrin saturation reflects the percentage of transferrin binding sites occupied by iron, providing insight into iron availability for cellular uptake in the brain. The ≤35% threshold captures patients with functional iron deficiency who may have "normal" ferritin but inadequate iron delivery to the central nervous system 2.
The ESRD exception: The lower TSAT threshold (<20%) in dialysis patients reflects altered iron metabolism in chronic kidney disease, where inflammation and hepcidin dysregulation affect iron utilization differently than in the general population 1.
Avoiding common pitfalls:
- Don't withhold iron therapy based solely on "normal" ferritin levels—check TSAT
- Don't use oral iron as first-line in moderate-to-severe RLS; IV formulations show superior efficacy 2
- Don't fear iron overload excessively; it occurs in only 2-5% of appropriately monitored patients 4
Treatment response timeline: Symptom improvement can occur rapidly—within 2 days with IV iron in some cases 5—though full response typically requires achieving target ferritin levels.